References
- Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 2000;163:1124–9.
- Miyazaki J, Hinotsu S, Ishizuka N, Naito S, Ozono S, Akaza H, et al. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer. Jpn J Clin Oncol 2013;43:827–34.
- Rischmann P, Desgrandchamps F, Malavaud B, Chopin DK. BCG intravesical instillations: recommendations for side-effects management. Eur Urol 2000;37:33–6.
- Nieder AM, Sved PDSJ, Skinner DG, Soloway MS. Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guérin-induced bladder contractures. Urology 2005;65:909–12.
- Glemain P, Rivière C, Lenormand L, Karam G, Bouchot O, Buzelin JM. Prolonged hydrodistention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year. Eur Urol 2002;41:79–84.
- Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L. Jr. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999;161:553–7.
- Hameed A, Sezian N, Thwaini A. Bladder contracture: review for intravesical bacillus Calmette-Guerin complication. Can J Urol 2007;14:3745–9.
- Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596–600.
- Nagayama T, Koyama A, Okoshi K, Oshima K. Assessment of contracted bladder following intravesical instillation of BCG (Japan). Gan to Kagaku Ryoho 2012;39:1681–5.
- Lynes WL, Flynn SD, Shortliffe LD, Stamey TA. The histology of interstitial cystitis. Am J Surg Pathol 1990;14:969–76.
- Sawada A, Yagihashi Y, Kawase N, Fukuzawa S. Bladder contracture following intravesical BCG immunotherapy treated by hydrodistention: a case report. Hinyokika Kiyo 2006;52:59–61.
- Tsushima T, Ara R, Seno Y. Experienced of bladder hydrodistention for irritative bladder symptom after intravesical BCG therapy. Hinyoki Geka 2009;22:193–4.
- Rabe HH, Gotoh M, Momose H. The place of cystoscopy and hydrodistension in the diagnosis of interstitial cystitis: a potpourri of opinions emanating from an International Consultation on IC in Kyoto, Japan, March 28-30, 2003. Int J Urol 2003;10:S16–S18.
- Nadasy KA, Patel RS, Emmett M, Murillo RA, Tribble MA, Black RD, et al. Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma. South Med J 2008;101:91–5.
- Sun YS, Lou SQ, Wen JM, Lv WX, Jiao CG, Yang SM, et al. Clinical value of polymerase chain reaction in the diagnosis of joint tuberculosis by detecting the DNA of Mycobacterium tuberculosis. Orthop Surg 2011;3:64–71.
- Wittes R, Klotz L, Kosecka U. Severe bacillus Calmette-Guerin cystitis responds to systemic steroids when antituberculous drugs and local steroids fail. J Urol 1999;161:1568–9.
- Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011;59:997–1008.